TWC
DTIL icon

TD Waterhouse Canada’s Precision BioSciences DTIL Stock Holding History

TD Waterhouse Canada’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6 Buy
+1
New +$5 ﹤0.01% 2291

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

TD Waterhouse Canada's DTIL Position: Q1 2026 in Review

TD Waterhouse Canada opened a new position in Precision BioSciences (DTIL) in Q1 2026: 1 share worth $6. The stake represents ﹤0.01% of the portfolio and ranks #2291 among its holdings.

78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • TD Waterhouse Canada held 1 share of Precision BioSciences worth $6 as of Q1 2026.
  • Precision BioSciences was a new TD Waterhouse Canada position in Q1 2026.
  • Precision BioSciences made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #2291 holding.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.